Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 9/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9213089 | 0.98 | TSHR (0.38) | EPHX1EPHX2TSHRNAAAMEN1 | |
| SCHEMBL9212423 | 0.97 | EPHX1 (0.44) | EPHX1EPHX2TSHRNAAASIGMAR1 | |
| SCHEMBL9213609 | 0.96 | MEN1 (0.39) | EPHX1EPHX2TSHRNAAAMEN1 | |
| SCHEMBL9207776 | 0.95 | EPHX1 (0.41) | EPHX1EPHX2TSHRNAAA | |
| SCHEMBL9204985 | 0.95 | EPHX1 (0.41) | EPHX1EPHX2TSHRNAAA | |
| SCHEMBL9206051 | 0.93 | EPHX1 (0.41) | EPHX1EPHX2TSHRNAAASIGMAR1 | |
| SCHEMBL11304162 | 0.93 | EPHX1 (0.41) | EPHX1EPHX2TSHRNAAASIGMAR1 | |
| SCHEMBL24219174 | 0.89 | MEN1 (0.39) | EPHX1EPHX2TSHRNAAAMEN1 | |
| SCHEMBL9206047 | 0.85 | BCHE (0.41) | EPHX1EPHX2TSHRNAAAMEN1 | |
| SCHEMBL23612403 | 0.84 | SHBG (0.43) | EPHX1EPHX2TSHRNAAASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0421441-B1 | Pantothenic acid derivatives | FUJIREBIO KK (JP) | 1995-01-25 | — | — | EP | disclosed |
| US-5120738-A | Cardiovascular disorders | FUJIREBIO INC. (JP) | 1992-06-09 | — | — | US | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |